Clinical Trials · NCT01677910
TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome)
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Lexicon Pharmaceuticals
- Enrollment
- 135
- Start date
- Jan 2013
- Locations
- 75 sites, 12 countries
- Primary endpoint
- Change From Baseline in the Number of Bowel Movements (BMs) Per Day Averaged Over 12 Weeks